(Q34076184)

30 July 2017

1 reference

title

Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? (English)

1 reference

30 July 2017

1 reference

Payne KA

1

1 reference

30 July 2017

Esmonde-White S

series ordinal

2

1 reference

30 July 2017

publication date

1 December 2000

1 reference

Current Hypertension Reports

30 July 2017

published in

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

515-524

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-996-0035-6

30 July 2017

exact match

0 references

cites work

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1007%2FS11906-996-0035-6

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-996-0035-6

Benefits of adherence to anti-hypertensive drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-996-0035-6

The effects of antihypertensive therapy on the quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-996-0035-6

Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-996-0035-6

Medication use by ambulatory elderly. An in-home survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-996-0035-6

Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

21 January 2018

1 reference

12 December 2020

Patients' experiences of antihypertensive drugs in routine use: results of a Danish general practice survey.

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization

1 reference

12 December 2020

Measuring patient compliance in antihypertensive therapy--some methodological aspects.

1 reference

12 December 2020

Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy.

1 reference

12 December 2020

Economic impact of cardiovascular disease in Canada

1 reference

12 December 2020

The determinants of hypertension awareness, treatment, and control in an insured population

1 reference

12 December 2020

Evidence-based medicine. A new approach to teaching the practice of medicine

1 reference

12 December 2020

Adherence to pharmacologic management of hypertension

1 reference

12 December 2020

Maintaining long-term control of blood pressure: The role of improved compliance

1 reference

12 December 2020

Compliance with antihypertensive therapy: raising the bar of expectations

1 reference

12 December 2020

Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Existing treatment strategies: does noncompliance make a difference?

1 reference

12 December 2020

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

12 December 2020

Integrated approaches to management of hypertension: promoting treatment acceptance

1 reference

12 December 2020

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

12 December 2020

Variations in compliance among hypertensive patients by drug class: implications for health care costs

1 reference

12 December 2020

Using healthcare claims data for outcomes research and pharmacoeconomic analyses

1 reference

12 December 2020

Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group

1 reference

12 December 2020

The impact of side effects on hypertension management: a Japanese survey

1 reference

12 December 2020

Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers

1 reference

12 December 2020

Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker

1 reference

12 December 2020

Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diuretics

1 reference

12 December 2020

Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study

1 reference

12 December 2020

Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies

1 reference

12 December 2020

Predicting Risk of Ischemic Heart Disease and Cerebrovascular Disease from Systolic and Diastolic Blood Pressures

1 reference

12 December 2020

Identification of the noncompliant hypertensive patient.

1 reference

12 December 2020

The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly

1 reference

12 December 2020

Changes in antihypertensive therapy--the role of adverse effects and compliance

1 reference

12 December 2020

Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?

1 reference

12 December 2020

Assessing compliance to antihypertensive medications using computer-based pharmacy records.

1 reference

12 December 2020

Improving compliance and increasing control of hypertension: needs of special hypertensive populations

1 reference

12 December 2020

Assessing patient wellness: new perspectives on quality of life and compliance.

1 reference

12 December 2020

Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care.

1 reference

12 December 2020

Real-world effectiveness of antihypertensive drugs.

1 reference

12 December 2020

Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 3: Angiotensin-converting-enzyme inhibitors.

1 reference

12 December 2020

Patient compliance with antihypertensive medication

1 reference

12 December 2020

Continuation of initial antihypertensive medication after 1 year of therapy.

1 reference

12 December 2020

The costs of interrupting antihypertensive drug therapy in a Medicaid population.

1 reference

12 December 2020

Major Risk Factors for Cardiovascular Disease Mortality in Adults: Results from the Nutrition Canada Survey Cohort

1 reference

12 December 2020

Compliance in hypertension: why don't patients take their pills?

1 reference

12 December 2020

An additional basic science for clinical medicine: II. The limitations of randomized trials

1 reference

12 December 2020

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

12 December 2020

10.1007/S11906-996-0035-6

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1024788740

0 references

1 reference